BioSpace News Archive

Smith+Nephew, the global medical technology company, unveils “Precision in Motion”, a franchise-level value proposition spanning its Robotics, Knee, and Hip portfolios within the Orthopaedics business.

Economic activity in the hospital subsector grew in February for the 33rd consecutive month, say the nation’s hospital supply executives in the latest Hospital ISM® Report On Business®.

Venatorx Pharmaceuticals today announced changes to its Board of Directors.

The National Marrow Donor Program® /Be The Match® in partnership with CIBMTR® and the National Institute of Health’s National Heart, Lung, and Blood Institute announced that the Journal of the American Medical Association published findings from the Pre-MEASURE study.

A diverse workforce is not only fundamental to the company’s future success, but it’s also a part of its rich history.

When Dr. Hacker, inventor of the Lumohs scalpel, watched surgeries being performed by Floating Doctors’ in remote clinics and villages, he knew he could help.

PENTAX Medical Americas, a division of HOYA Group, is excited to announce that it has obtained CE marks, clearing it for commercialization in the European Union for two of its latest innovations: the PENTAX Medical INSPIRA™ premium video processor and the i20c video endoscope series.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

BioCorRx Inc.(OTCQB: BICX) (the “Company”), a clinical-stage developer and provider of innovative treatment programs for substance use and related disorders, has announced interim positive safety and pharmacokinetic (PK) results for the Phase I clinical trial of the Company’s BICX104 implantable naltrexone pellet.

Chinook Therapeutics, Inc. today announced that Chinook management is scheduled to participate in a virtual fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on Tuesday, March 14, 2023 at 3:20 pm ET, as well as 1x1 meetings.